Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Bridging anticoagulation may raise post-surgery bleeding risks.

Too much thymosin beta4 causes weird teeth and more hair growth in mice.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.